Type 1

Type 2

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1417550924.jpg?itok=XXl-0S6h

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1417550924.jpg?itok=S_lcRviI

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1417550924.jpg?itok=Hw1aeMGm

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1417550924.jpg?itok=SlDFXlqw

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1417550924.jpg?itok=OY5qwZM3

8 Apps to Improve Your Time in Range

Managing your Time in Range (TIR) can be challenging, but there are several apps you can download to help you. In this article, we cover 14 apps you may want to check out.

Gestational

Prediabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/glucometer-and-phone.jpg?itok=ywoTU80Z

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/glucometer-and-phone.jpg?itok=lTevtlyf

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/glucometer-and-phone.jpg?itok=XpbjcB07

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/glucometer-and-phone.jpg?itok=4eCsA9qS

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/glucometer-and-phone.jpg?itok=NCa0i7dg

glucometer-and-phone.jpg

[node:summary] Track blood sugar trends with free apps like mySugr, Tidepool, Glucose Buddy, and Glooko. These apps sync with smartphones and provide comprehensive insights, helping manage diabetes effectively.

4 Free Apps That Sync With Blood Glucose Meters

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2025-01/abbott-lingo_1.jpg?itok=FRaaoPC4

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2025-01/abbott-lingo_1.jpg?itok=nbV2rjzi

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2025-01/abbott-lingo_1.jpg?itok=zz4oi3YT

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2025-01/abbott-lingo_1.jpg?itok=-ZdQvXLA

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2025-01/abbott-lingo_1.jpg?itok=Sx1ZCL10

abbott-lingo.jpg

Curious about Abbott's Lingo, an over-the-counter continuous glucose monitor for people without diabetes, the diaTribe staff decided to try it out.

diaTribe Reviews: Lingo by Abbott

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2025-01/abbott-lingo.jpg?itok=9x6tHfO4

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2025-01/abbott-lingo.jpg?itok=a0fRIOmb

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2025-01/abbott-lingo.jpg?itok=Xp75FQpF

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2025-01/abbott-lingo.jpg?itok=qCwJ8fqw

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2025-01/abbott-lingo.jpg?itok=Z2owBHzL

Best-selling author and diaTribe contributor Jim Hirsch shares his experience trying out the first over-the-counter CGMs to hit the market.  

CGM Breakthrough Opens New Markets for Sensor Technology

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2025-01/dexcom-g7-iphone-horizontal.jpg?itok=8KCzJm73

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2025-01/dexcom-g7-iphone-horizontal.jpg?itok=7nT1CI5n

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2025-01/dexcom-g7-iphone-horizontal.jpg?itok=Tkt2slva

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2025-01/dexcom-g7-iphone-horizontal.jpg?itok=mxeirX7o

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2025-01/dexcom-g7-iphone-horizontal.jpg?itok=q_C2jxp6

dexcom-g7-iphone-horizontal.jpg

With so many things happening in the diabetes tech world, it can be hard to keep up. Stay up-to-date here with the latest diabetes tech news and alerts.

Tech Watch: The Latest in Diabetes Tech News

Tech Watch: Dexcom G7 App Update, New Virtual Endo Service

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/control-iq-2.png?itok=wuOLnMA8

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/control-iq-2.png?itok=WVDSiHZE

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/control-iq-2.png?itok=7vfA2h6F

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/control-iq-2.png?itok=VRZXYIyh

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/control-iq-2.png?itok=yT2R7M7P

Tandem’s Control-IQ Cleared in United States

Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch&nbsp;in&nbsp;January 2020

Control-IQ is an insulin algorithm or calculator used in Tandem's t:slim X2 and Mobi insulin pumps. Control-IQ adjusts basal insulin delivery every five minutes to prevent highs and lows and increase time in range.

 Tandem Control-IQ: How It Works, Features, and Latest Updates

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/tandem-mobi-arm-view.jpeg?itok=RiaewtkG

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/tandem-mobi-arm-view.jpeg?itok=LY562QdM

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/tandem-mobi-arm-view.jpeg?itok=zBkdvUmg

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/tandem-mobi-arm-view.jpeg?itok=iJlNog9v

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/tandem-mobi-arm-view.jpeg?itok=bwd6-R2Q

Tandem Mobi Automated Insulin Delivery System Now Available

Tandem’s Mobi automated insulin delivery system has officially launched in the U.S. The world’s smallest insulin delivery system to be fully controlled by a smartphone is now shipping, with orders processed on a first-come, first-served basis.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-11/mri-tech_0.jpg?itok=P7z10iGj

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-11/mri-tech_0.jpg?itok=tYoqfaR0

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-11/mri-tech_0.jpg?itok=qyAfBNIP

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-11/mri-tech_0.jpg?itok=AOBk41vD

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-11/mri-tech_0.jpg?itok=ambbBl7w

mri-tech_0.jpg

FreeStyle Libre CGM Cleared for Use During Imaging Tests

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-10/nightscout-main-view.jpg?itok=DXlSKKrT

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-10/nightscout-main-view.jpg?itok=RCILDvLI

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-10/nightscout-main-view.jpg?itok=RqqjGJeE

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-10/nightscout-main-view.jpg?itok=duyiH9kI

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-10/nightscout-main-view.jpg?itok=kwy_e2ST

nightscout-main-view.jpg

A web-based tool that grew out of the worldwide DIY diabetes community helps people see actionable blood sugar and treatment data all in one place.


Nightscout: How To Get Started With CGM in the Cloud

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-09/cgm-bike.jpg?itok=kX_yyPoT

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-09/cgm-bike.jpg?itok=DW4BWWlO

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-09/cgm-bike.jpg?itok=l0xSC9pO

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-09/cgm-bike.jpg?itok=BCQhyzlX

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-09/cgm-bike.jpg?itok=aEnEZs2m

cgm-bike.jpg

Get tips on talking with your doctor, what to know about starting with CGM and how to share your results with your healthcare team. 

How To Start Using a CGM

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/screen-shot-2023-06-19-at-11.07.54-am.png?itok=WidjgZjy

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/screen-shot-2023-06-19-at-11.07.54-am.png?itok=OJba9o-G

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/screen-shot-2023-06-19-at-11.07.54-am.png?itok=OJLRGyHl

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/screen-shot-2023-06-19-at-11.07.54-am.png?itok=Ql4DAFbA

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/screen-shot-2023-06-19-at-11.07.54-am.png?itok=RSRKG-tL

Medtronic MiniMed 780G Now Available in the US, Covered by Medicare

Learn about the automated insulin delivery system's features, how it works, what it costs — and get the latest news.

Learn about the automated insulin delivery system's features, how it works, what it costs – and get the latest news.

Medtronic MiniMed 780G: Overview, Features, and News

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/woman-with-cgm-overlay-630.jpg?itok=z_6ukXfB

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/woman-with-cgm-overlay-630.jpg?itok=t6aIEDLX

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/woman-with-cgm-overlay-630.jpg?itok=sC90WWo-

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/woman-with-cgm-overlay-630.jpg?itok=fZa6oOVe

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/woman-with-cgm-overlay-630.jpg?itok=KwOB2PP7

woman-with-cgm-overlay-630.jpg

Here's how to take care of your continuous glucose monitor so it stays secure, accurate and on the job.

7 Common CGM Hang-Ups (and How to Get Around Them)

7 Common CGM Hang-Ups (and How To Get Around Them)

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/insulin-pump-horizontal.jpg?itok=rwPup3aW

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/insulin-pump-horizontal.jpg?itok=0qhmBKrI

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/insulin-pump-horizontal.jpg?itok=A7aKJHGu

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/insulin-pump-horizontal.jpg?itok=owW1PPuA

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/insulin-pump-horizontal.jpg?itok=CIce2vca

insulin-pump-horizontal.jpg

Researchers, advocates, and people with diabetes offer guidance for dealing with daily difficulties, plus how to get involved in the next breakthrough treatments.

Diabetes Challenges, Search for a Cure, and How to Help

Diabetes Challenges, the Search for a Cure, and How to Help

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/accucheck-smartguide.jpg?itok=V5WtP5-D

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/accucheck-smartguide.jpg?itok=JbZyXTaC

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/accucheck-smartguide.jpg?itok=cwMh96Ti

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/accucheck-smartguide.jpg?itok=2tXrBs6d

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/accucheck-smartguide.jpg?itok=poQscwfV

accucheck-smartguide.jpg

A new continuous glucose monitor, the Accu-Chek SmartGuide, can predict the risk of hypoglycemia from 30 minutes to seven hours ahead. The device is approved in Europe, with future U.S. approval planned.

AI-enhanced CGM, Approved in Europe, Predicts Nighttime Hypo Risk Risk Up to 7 Hours 

AI-Enhanced CGM Approved in Europe

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-07/woman-reviewing-cgm-readings.jpg?itok=Z9-pUT2L

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-07/woman-reviewing-cgm-readings.jpg?itok=u2F7VNwi

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-07/woman-reviewing-cgm-readings.jpg?itok=yjvPqC9B

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-07/woman-reviewing-cgm-readings.jpg?itok=fqHne_3W

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-07/woman-reviewing-cgm-readings.jpg?itok=eVqCa82x

woman-reviewing-cgm-readings.jpg

[node:summary] Continuous glucose monitors are an essential tool for managing blood sugar, but only if you know how to interpret the data. 

Continuous glucose monitors are an essential tool for managing blood sugar, but only if you know how to interpret the data. Here are our best tips. 

How To Make Sense of CGM Data[node:title] | [site:name]

How To Make Sense of CGM Data

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2025-01/istock-1799537140.jpg?itok=6ivaT3eE

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2025-01/istock-1799537140.jpg?itok=i1vJBOih

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2025-01/istock-1799537140.jpg?itok=cRKwh_9f

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2025-01/istock-1799537140.jpg?itok=Ki0zsDjc

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2025-01/istock-1799537140.jpg?itok=7X0v59ju

istock-1799537140.jpg

A trial is recruiting adults with type 1 diabetes and chronic kidney disease to investigate the drug sotagliflozin for protecting kidney function. Despite concerns about diabetic ketoacidosis, previous research suggests that a DKA prevention plan can minimize risks.

Join Trial Studying New Treatment for Type 1 Diabetes and Chronic Kidney Disease

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-1393991963_0.jpg?itok=jEmLfCp1

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-1393991963_0.jpg?itok=kIT6Y0DV

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-1393991963_0.jpg?itok=2BB7G2KH

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-1393991963_0.jpg?itok=fN8XkaPW

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-1393991963_0.jpg?itok=zvvxJEw7

New Weight Loss Drug CagriSema Shows Impressive Results in Clinical Trials

Uncover phase 2 clinical trial results of CagriSema, a&nbsp;promising diabetes treatment showing improvements in&nbsp;A1C, weight loss, and time in range.

CagriSema is a once-weekly injection of semaglutide and cagrilintide. CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising new type 2 diabetes and weight management treatment.  

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-12/istock-2178382825.jpg?itok=TEjNNhc-

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-12/istock-2178382825.jpg?itok=VJ9l-3Wr

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-12/istock-2178382825.jpg?itok=NFl6JjkC

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-12/istock-2178382825.jpg?itok=mHkJR5eZ

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-12/istock-2178382825.jpg?itok=pU8896M2

istock-2178382825.jpg

In a recent clinical trial, tirzepatide (Zepbound) achieved 47% greater weight loss compared to semaglutide (Wegovy), with average weight loss over 72 weeks of roughly 20 pounds.

Zepbound Outshines Wegovy in Major Weight Loss Trial

Zepbound Shows Greater Weight Loss Than Wegovy in Major Trial

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-12/istock-2155855105.jpg?itok=9U_ymvqn

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-12/istock-2155855105.jpg?itok=LwXMhZpT

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-12/istock-2155855105.jpg?itok=IToLctUa

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-12/istock-2155855105.jpg?itok=P52DY6Uj

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-12/istock-2155855105.jpg?itok=34fuBwkz

istock-2155855105.jpg

Research finds that the experimental drug MariTide, a once-monthly injection, resulted in significant weight loss in people with obesity and type 2 diabetes.

New Drug MariTide Shows Promising Weight Loss Results 

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-12/istock-1391438704_0.jpg?itok=gHoBzQaH

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-12/istock-1391438704_0.jpg?itok=cPGpWQNh

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-12/istock-1391438704_0.jpg?itok=A43HD2hW

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-12/istock-1391438704_0.jpg?itok=eXeKOvi6

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-12/istock-1391438704_0.jpg?itok=aVrHX4rv

istock-1391438704.jpg

A trial is recruiting adults with type 2 diabetes and diabetic kidney disease to investigate an injection into the kidney that could potentially preserve kidney function. The drug has already shown promising results in a phase 2 study, especially in participants with the highest risk of kidney failure.

Join Trial Studying New Treatment for Type 2 Diabetes and Chronic Kidney Disease

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-08/surmount-1-istock-1492726899.jpg?itok=Cmvczbvy

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-08/surmount-1-istock-1492726899.jpg?itok=GgCHxvsh

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-08/surmount-1-istock-1492726899.jpg?itok=Vh_1yA1Z

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-08/surmount-1-istock-1492726899.jpg?itok=XfCQx8Q6

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-08/surmount-1-istock-1492726899.jpg?itok=EaZ69sK1

surmount-1-istock-1492726899.jpg

[node:summary] URMOUNT-1 clinical trial shows tirzepatide (marketed as Mounjaro, Zepbound) prevented the progression of prediabetes to type 2 diabetes by 99%.

Zepbound Reversed Prediabetes, Prevented Progression to Type 2 for Nearly Everyone, Study Shows

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-11/man-taking-walk.jpg?itok=otQYHkHN

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-11/man-taking-walk.jpg?itok=uqhBz3Yt

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-11/man-taking-walk.jpg?itok=cl79DyAM

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-11/man-taking-walk.jpg?itok=RyMguXPS

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-11/man-taking-walk.jpg?itok=cKJI3kUT

man-taking-walk.jpg

Tips for Weight Loss Medications When You Have Diabetes

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/article/istock-666792964.jpg?itok=dU4Q7j_R

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/article/istock-666792964.jpg?itok=28HazR20

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/article/istock-666792964.jpg?itok=GV5dv9Ut

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/article/istock-666792964.jpg?itok=0wK-vfd2

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/article/istock-666792964.jpg?itok=qCu8F1Lt

Rybelsus Now First Line Therapy for Type 2 Diabetes

The FDA has just announced that Rybelsus has now been approved as an initial treatment option for type 2 diabetes. In addition to the glucose-lowering effects, Rybelsus has also been found to help protect the heart.

Rybelsus is an oral diabetes medication that helps lower blood sugar levels and protect against cardiovascular-related events like heart attacks and stroke.

https://api.diatribe.org/sites/default/files/styles/content_card_small/public/2024-12/istock-1740860355.jpg?itok=cTEqnVo_

https://api.diatribe.org/sites/default/files/styles/content_hero_large/public/2024-12/istock-1740860355.jpg?itok=7UAQVQW6

https://api.diatribe.org/sites/default/files/styles/content_hero_small/public/2024-12/istock-1740860355.jpg?itok=OzyyW-Tq

https://api.diatribe.org/sites/default/files/styles/content_teaser_large/public/2024-12/istock-1740860355.jpg?itok=5meYnSWC

https://api.diatribe.org/sites/default/files/styles/content_teaser_small/public/2024-12/istock-1740860355.jpg?itok=qKwAqcmo

istock-1740860355.jpg

Managing diabetes around the holidays can be extra challenging, but some simple adjustments to your diabetes management plan can help you feel more prepared.

Share

With New Diabetes Data, Our CEO Issues a Call to Action

More News on Diabetes Technologies

8 Apps to Improve Your Time in Range

4 Free Apps That Sync With Blood Glucose Meters

diaTribe Reviews: Lingo by Abbott

CGM Breakthrough Opens New Markets for Sensor Technology

Tech Watch: Dexcom G7 App Update, New Virtual Endo Service

Tandem Control-IQ: How It Works, Features, and Latest Updates

Tandem Mobi Automated Insulin Delivery System Now Available

FreeStyle Libre CGM Cleared for Use During Imaging Tests

More News on Diabetes Therapies

Join Trial Studying New Treatment for Type 1 Diabetes and Chronic Kidney Disease

New Weight Loss Drug CagriSema Shows Impressive Results in Clinical Trials

Zepbound Shows Greater Weight Loss Than Wegovy in Major Trial

New Drug MariTide Shows Promising Weight Loss Results

Join Trial Studying New Treatment for Type 2 Diabetes and Chronic Kidney Disease

Zepbound Reversed Prediabetes, Prevented Progression to Type 2 for Nearly Everyone, Study Shows

Tips for Weight Loss Medications When You Have Diabetes

Rybelsus Now First Line Therapy for Type 2 Diabetes

Latest Stories About Diabetes Stigma

dStigmatizing Holiday Meals With Diabetes

How Acceptance-Based Therapy Can Benefit People With Diabetes

5 Minutes With Dietitian Sue-Ellen Anderson-Haynes

Halloween with Diabetes: Navigating the Holiday Safely

Spoonful of Laughter: Defeating Diabetes Stigma With Comedy

Diabetes Can Be Hilarious – Just Ask Sam Morrison

Who Else Is High?

How Comedian Ashley Monique Became a Diabetes Ally

Latest Stories About Time in Range

8 Apps to Improve Your Time in Range

Nightscout: How To Get Started With CGM in the Cloud

How To Start Using a CGM

Medtronic MiniMed 780G: Overview, Features, and News

7 Common CGM Hang-Ups (and How To Get Around Them)

Diabetes Challenges, the Search for a Cure, and How to Help

AI-Enhanced CGM Approved in Europe

How To Make Sense of CGM Data